VTI visioneering technologies inc.

Ann: VTI releases full 1-years results of PROTECT Clinical Trial, page-4

  1. 2,958 Posts.
    lightbulb Created with Sketch. 154
    The SP could easily double based on results of RCT and our MC would still only be around $22M. It also cheep considering our annual revenue is around US$10M with a lot of space to improve in near future. Mr Market is always future looking... The time will tell.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.